UPDATE 2-Roche: Tecentriq cocktail slows kidney cancer progression By: Reuters: Company News December 11, 2017 at 06:23 AM EST * Swiss drugmaker aims to expand drug's indications (Adds analyst comment, shares) Read More >> Related Stocks: Bristol-Myers Squibb Merck & Co Rogers Corp